Arkansas State University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.astate.edu
DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
- Conditions
- Waldenstrom Macroglobulinemia
- Interventions
- Drug: DT PACE + Rituxan
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2011-08-26
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 12
- Registration Number
- NCT00107614
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-10-01
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 315
- Registration Number
- NCT00093028
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Biological: MAGE-A3Biological: MAGE-A3 AND NY-ESO-1 IMMUNOTHERAPY
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 4
- Registration Number
- NCT00090493
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-08-06
- Last Posted Date
- 2012-04-19
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 10
- Registration Number
- NCT00089453
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-06-04
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 190
- Registration Number
- NCT00083902
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-06-04
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 500
- Registration Number
- NCT00083876
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2004-06-04
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 97
- Registration Number
- NCT00083915
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia
- Conditions
- Waldenstrom Macroglobulinemia
- First Posted Date
- 2004-05-31
- Last Posted Date
- 2010-07-05
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 40
- Registration Number
- NCT00083707
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2004-05-31
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 25
- Registration Number
- NCT00083694
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-05-28
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 180
- Registration Number
- NCT00083681
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States